The F.D.A. Approves a New Pill to Slash Cholesterol Levels
The FDA has granted approval for Lipfendra, the first oral PCSK9 cholesterol-lowering treatment developed by Merck.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
What happened
The FDA has officially approved Lipfendra, a new daily oral medication developed by Merck designed to lower cholesterol levels. This development marks the first time a PCSK9-inhibiting treatment has been authorized in pill form, serving as an alternative to existing injectable medications.
Reports emphasize that the drug functions similarly to injectable treatments but provides an oral delivery method for patients requiring cholesterol management. Future updates will likely clarify specific availability and patient access timelines.
Current coverage does not yet specify detailed rollout schedules or insurance coverage frameworks.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (83% supported) Updated 42d ago.
Coverage (27)
- A Novel Pill For Cholesterol: FDA Approves Lipfendra Forbes · 45d ago
- FDA approves 1st-of-its-kind pill to reduce cholesterol ABC News - Breaking News, Latest News and Videos · 45d ago
- Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment Fierce Pharma · 45d ago
- FDA approves Merck’s first-of-its-kind oral cholesterol drug Lip-Fendra, company says WJLA · 45d ago
- FDA approves breakthrough daily pill for cholesterol WTOP · 45d ago
- What is the new FDA-approved pill designed to slash cholesterol levels? KTLA · 45d ago
- FDA approves new cholesterol-lowering drug NPR · 45d ago
- Cholesterol pill approved by FDA, billed as first of its kind, similar to injectable drugs Cleveland.com · 45d ago
- FDA approves first-of-its-kind cholesterol pill Lipfendra: What it will cost Yahoo Finance · 45d ago
- FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients AP News · 45d ago
- FDA nod to Merck's cholesterol pill opens a new frontier in cardiovascular care Baton Rouge Business Report · 45d ago
- FDA approves first daily pill to drastically lower cholesterol levels The Hill · 45d ago
- Should you take the powerful new cholesterol pill approved by the FDA? The Washington Post · 45d ago
- FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients Boston.com · 45d ago
- Game-changing cholesterol pill wins FDA approval after cutting LDL nearly 60% Fox News · 45d ago
- FDA approves first-of-its-kind cholesterol pill 10TV · 45d ago
- FDA Clears First Cholesterol Pill To Rival Costly Injections U.S. News & World Report · 45d ago
- Drugmaker Merck announces approval of new cholesterol-fighting drug The Guardian · 45d ago
- Merck’s cholesterol pill gets US FDA approval CNN · 45d ago
- U.S. approves pill for cholesterol that drives levels down far below statins Scientific American · 45d ago
- Merck beats AstraZeneca to first approval for first PCSK9 pill Endpoints News · 45d ago
- FDA approves new kind of cholesterol pill NBC News · 45d ago
- Merck Gets Approval for Powerful Cholesterol-Cutting Pill Barron's · 45d ago
- Merck Wins FDA Approval for a Powerful New Cholesterol Pill Bloomberg.com · 45d ago
- Merck's cholesterol pill gets US FDA approval Reuters · 45d ago
- Merck’s First-of-Its-Kind Cholesterol Pill Approved, Ushering in New Wave of Treatment WSJ · 45d ago
- The F.D.A. Approves a New Pill to Slash Cholesterol Levels The New York Times · 45d ago
Questions people are asking
What is Lipfendra?
Lipfendra is a daily oral cholesterol-lowering medication developed by Merck and recently approved by the FDA.
How does this drug differ from previous treatments?
It is the world's first oral PCSK9 treatment, providing an alternative to traditional injectable cholesterol drugs.
Is information available on the cost of the drug?
While media outlets mention the topic of cost, coverage does not currently specify pricing details.
Topics
Related trends
CEOs Pushed White House to Delay Ultra-Processed Food Policy
Corporate lobbying and White House maneuvering have collided over the FDA's controversial new ultra-processed food definition.
FDA Announces Recall on Berries Sold in 8 States for Potential E. Coli Contamination
The FDA and Publix have issued a recall for frozen berries across eight states following an E. coli outbreak linked to the products.
More cases reported in cyclospora outbreak not linked to lettuce: FDA data
Cyclospora infections are rising across the U.S., with recent data indicating new outbreak clusters that fall outside the traditional link to lettuce products.
Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues
Sanofi’s new CEO Garijo outlines an R&D restructuring and expansion plan as the company balances strong second-quarter earnings against investor concerns.
GLP-1 weight loss drugs: What experts say about keeping weight off after stopping
Medical professionals are reevaluating obesity treatment protocols as GLP-1 usage rises and questions emerge regarding long-term dependency and patient age limits.
Can you eat lettuce safely during the cyclospora outbreak? Advice from an infectious disease expert
Cyclospora outbreaks are fueling regional health concerns and economic strain in the restaurant industry as officials navigate complex data and public messaging.